Active Ingredient History
An essential amino acid, or indispensable amino acid, is an amino acid that cannot be synthesized from scratch by the organism fast enough to supply its demand, and must therefore come from the diet. Of the 21 amino acids common to all life forms, the nine amino acids humans cannot synthesize are valine, isoleucine, leucine, methionine, phenylalanine, tryptophan, threonine, histidine, and lysine. Wikipedia
Combination drugs
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Nitrogen (approved 1971)
Aging (Phase 1)
Anemia (Phase 2/Phase 3)
Anorexia Nervosa (Phase 2)
Ascites (Phase 4)
Atrophy (Phase 4)
Attention Deficit Disorder with Hyperactivity (Phase 1/Phase 2)
Bariatric Surgery (Phase 4)
Brain Concussion (Phase 2)
Breast Neoplasms (Phase 2)
Carcinoid Tumor (Phase 2)
Child Development (Phase 4)
Colorectal Neoplasms (Phase 4)
COVID-19 (Phase 2/Phase 3)
Critical Illness (Phase 4)
Cystectomy (Phase 4)
Dental Plaque (Phase 3)
Dermatitis, Atopic (Phase 3)
Diabetes Mellitus, Type 2 (Phase 4)
Dialysis (Phase 4)
Diarrhea (Phase 4)
Diet, Protein-Restricted (Phase 4)
Eczema (Phase 3)
Enteral Nutrition (Phase 4)
Fatigue Syndrome, Chronic (Phase 1)
Femur Head Necrosis (Phase 2)
Fibrosis (Phase 4)
General Surgery (Phase 4)
Geriatrics (Phase 4)
Growth and Development (Phase 2/Phase 3)
Healthy Volunteers (Phase 4)
Hepatic Encephalopathy (Phase 4)
Hip Fractures (Phase 2)
HIV Infections (Phase 3)
Infections (Phase 4)
Inflammation (Phase 4)
Insulin-Like Growth Factor I (Phase 2)
Intestinal Diseases (Phase 4)
Iron Deficiencies (Phase 4)
Kidney Diseases (Phase 2)
Kidney Failure, Chronic (Early Phase 1)
Kwashiorkor (Phase 1)
Laparotomy (Phase 4)
Lung Diseases (Phase 2)
Malnutrition (Phase 4)
Medulloblastoma (Phase 2)
Meningioma (Phase 2)
Mesenteric Ischemia (Phase 4)
Metabolic Diseases (Early Phase 1)
Milk Hypersensitivity (Phase 3)
Multiple Organ Failure (Phase 4)
Muscle Hypotonia (Phase 1/Phase 2)
Muscles (Phase 4)
Muscle Weakness (Phase 4)
Muscular Atrophy (Phase 2)
Neoplasms (Phase 4)
Nervous System Diseases (Phase 3)
Neuroblastoma (Phase 2)
Neuroendocrine Tumors (Phase 3)
Non-alcoholic Fatty Liver Disease (Phase 2)
Nutrition Therapy (Phase 3)
Obesity (Phase 4)
Obesity, Morbid (Phase 4)
Osteoarthritis (Phase 2)
Overweight (Phase 2)
Paraganglioma (Phase 2)
Parenteral Nutrition (Phase 3)
Parents (Phase 3)
Phenylketonurias (Phase 4)
Pheochromocytoma (Phase 2)
Postural Balance (Phase 3)
Prediabetic State (Phase 3)
Pregnancy Complications (Early Phase 1)
Premature Birth (Phase 4)
Protein-Energy Malnutrition (Phase 1)
Quality of Life (Phase 2)
Renal Insufficiency (Phase 2)
Respiratory Tract Infections (Phase 4)
Sarcopenia (Phase 1)
Sleep Apnea Syndromes (Phase 3)
Survival (Phase 4)
Thoracic Surgery (Phase 3)
Thyroid Neoplasms (Phase 2)
Tissue Adhesions (Phase 1)
Triple Negative Breast Neoplasms (Phase 2)
Uremia (Phase 4)
Urinary Bladder Neoplasms (Phase 4)
Urinary Tract Infections (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue